Sanjit S Jolly, David P Faxon, Keith AA Fox, Rizwan Afzal, William E Boden, Petr Widimsky, P Gabriel Steg, Vicent Valentin, Andrez Budaj, Christopher B Granger, Campbell D Joyner, Susan Chrolavicius, Salim Yusuf, Shamir R Mehta, None,
Efficacy and safety of fondaparinux versus enoxaparin in patients with acute coronary syndromes treated with glycoprotein IIb/IIIa inhibitors or thienopyridines: results from the OASIS 5 (Fifth Organization to Assess Strategies in Ischemic Syndromes) trial. Journal of the American College of Cardiology. ,vol. 54, pp. 468- 476 ,(2009) ,
10.1016/J.JACC.2009.03.062